Completed OBSERVATIONAL NCT03410758

Predictive Factors of Survival With and Without Repetition With 5 and 10 Years Curative Post-oesophagectomy for Cancer of the Oesophagus (RESARPO)

Sponsor: University Hospital, Brest

Conditions Esophageal Cancer Esophageal Surgery Cancer Overall Survival

Updated 7 times since 2018 Last updated: Feb 6, 2018 Started: Feb 15, 2016 Primary completion: Dec 31, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Esophageal Cancer and Esophageal Surgery Cancer, this trial is completed. The trial is conducted by University Hospital, Brest and has accumulated 7 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 2 earlier versions

Mar 2018 — Apr 2018 [monthly]

Completed NA
Feb 2018 — Mar 2018 [monthly]

Completed NA

First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Brest

Data source: University Hospital, Brest

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brest, France